Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.08 USD | +3.17% | +9.41% | +16.66% |
04-18 | Transmedics Group Insider Sold Shares Worth $380,480, According to a Recent SEC Filing | MT |
04-05 | Transmedics Group Insider Sold Shares Worth $802,084, According to a Recent SEC Filing | MT |
Evolution of the average Target Price on TransMedics Group, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering TransMedics Group, Inc.
Piper Sandler | |
Oppenheimer | |
Morgan Stanley | |
William Blair & Co. | |
Canaccord Genuity | |
Cowen | |
JPMorgan Chase |
EPS Revisions
- Stock Market
- Equities
- TMDX Stock
- Consensus TransMedics Group, Inc.